NCT04430699 2026-03-19
Cisplatin+Pembrolizumab+RT in Vulvar Cancer
Massachusetts General Hospital
Phase 2 Active not recruiting
Massachusetts General Hospital
Dana-Farber Cancer Institute
Xi'an Jiaotong University
Instituto do Cancer do Estado de São Paulo
Alliance for Clinical Trials in Oncology